NeuroPace $102 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Alkami Technology $207 million IPO
We advised the underwriters on the IPO and Nasdaq listing
VIZIO Holding $257.2 million IPO
We advised the underwriters on the IPO and NYSE listing
Twitter $1.25 billion convertible senior notes offering
The Rule 144A offering involved 0% convertible notes due 2026
AVITA Medical $69.1 million follow-on offering
We advised the underwriters on the equity offering
Endurance International Group $685 million senior notes offering
We advised the initial purchasers on the high-yield notes offering
Plug Power $1.82 billion stock offering
We advised the underwriters in connection with the SEC-registered offering
RAPT Therapeutics $100 million at-the-market offering
Davis Polk advised the sales agents on the SEC-registered at-the-market offering by RAPT Therapeutics, Inc. of its common stock for up to an aggregate amount of $100 million.
RAPT…
Signify Health acquisition of PatientBlox
Davis Polk advised Signify Health on its acquisition of PatientBlox. The acquisition accelerates Signify’s prospective provider payment capabilities for episodes of care, supporting the…
Plug Power $845.5 million stock offering
Davis Polk advised the representative of the several underwriters in connection with the SEC-registered offering of 38,000,000 shares of common stock of Plug Power Inc. for $845.5…